Want to see FR:BLC full AI Analyst Report?
Bastide le Confort Medical (BLC) Ratios
9 Followers
Bastide le Confort Medical Ratios
FR:BLC's free cash flow for Q4 2026 was €12.49M. For the 2026 fiscal year, FR:BLC's free cash flow was decreased by €-24.43M and operating cash flow was €36.93M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Sep 25 | Sep 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.20 | 1.38 | 0.97 | 0.87 | 1.07 |
| Quick Ratio | 0.97 | 1.18 | 0.69 | 0.60 | 0.72 |
| Cash Ratio | 0.29 | 0.13 | 0.11 | 0.16 | 0.13 |
| Solvency Ratio | 0.27 | 0.10 | 0.11 | 0.12 | 0.13 |
| Operating Cash Flow Ratio | 0.49 | 0.51 | 0.31 | 0.40 | 0.27 |
| Short-Term Operating Cash Flow Coverage | 2.76 | 9.12 | 1.38 | 1.19 | 1.19 |
| Net Current Asset Value | € -242.61M | € -313.14M | € -357.42M | € -372.58M | € -359.25M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.52 | 0.62 | 0.63 | 0.65 | 0.66 |
| Debt-to-Equity Ratio | 2.28 | 5.70 | 5.12 | 4.88 | 4.96 |
| Debt-to-Capital Ratio | 0.70 | 0.85 | 0.84 | 0.83 | 0.83 |
| Long-Term Debt-to-Capital Ratio | 0.65 | 0.83 | 0.78 | 0.76 | 0.78 |
| Financial Leverage Ratio | 4.39 | 9.16 | 8.11 | 7.50 | 7.48 |
| Debt Service Coverage Ratio | 1.89 | 2.27 | 1.33 | 1.00 | 1.61 |
| Interest Coverage Ratio | 1.89 | 1.27 | 1.42 | 2.21 | 2.55 |
| Debt to Market Cap | 1.55 | 1.52 | 2.37 | 1.55 | 1.30 |
| Interest Debt Per Share | 43.78 | 59.18 | 58.44 | 55.93 | 58.79 |
| Net Debt to EBITDA | 2.39 | 3.78 | 3.59 | 3.98 | 4.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 10.55% | 67.80% | 66.91% | 65.69% | 65.51% |
| EBIT Margin | 9.17% | 8.43% | 8.28% | 7.75% | 7.21% |
| EBITDA Margin | 21.74% | 20.77% | 20.24% | 19.32% | 19.18% |
| Operating Profit Margin | 9.17% | 7.97% | 7.35% | 7.22% | 6.95% |
| Pretax Profit Margin | 3.02% | 2.15% | 3.12% | 4.48% | 4.49% |
| Net Profit Margin | 12.04% | 0.11% | -0.17% | 2.37% | 2.92% |
| Continuous Operations Profit Margin | 2.07% | 0.82% | 1.79% | 3.31% | 3.22% |
| Net Income Per EBT | 398.56% | 5.01% | -5.45% | 52.92% | 65.10% |
| EBT Per EBIT | 32.96% | 26.91% | 42.40% | 62.10% | 64.57% |
| Return on Assets (ROA) | 10.09% | 0.08% | -0.14% | 1.83% | 2.16% |
| Return on Equity (ROE) | 44.33% | 0.73% | -1.13% | 13.74% | 16.18% |
| Return on Capital Employed (ROCE) | 10.86% | 8.50% | 9.03% | 8.48% | 7.11% |
| Return on Invested Capital (ROIC) | 6.94% | 3.07% | 4.50% | 5.16% | 4.55% |
| Return on Tangible Assets | 14.87% | 0.11% | -0.21% | 6.10% | 7.24% |
| Earnings Yield | 33.43% | 0.23% | -0.63% | 5.31% | 5.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.37 | 4.97 | 4.94 | 5.29 | 4.88 |
| Payables Turnover | 5.17 | 2.13 | 2.28 | 2.39 | 2.53 |
| Inventory Turnover | 11.29 | 3.96 | 2.97 | 2.89 | 2.63 |
| Fixed Asset Turnover | 2.70 | 2.68 | 2.54 | 2.42 | 2.25 |
| Asset Turnover | 0.84 | 0.74 | 0.82 | 0.77 | 0.74 |
| Working Capital Turnover Ratio | 8.75 | 14.21 | -29.55 | -60.00 | 33.65 |
| Cash Conversion Cycle | 45.35 | -5.64 | 36.50 | 42.51 | 69.51 |
| Days of Sales Outstanding | 83.57 | 73.51 | 73.88 | 69.06 | 74.74 |
| Days of Inventory Outstanding | 32.32 | 92.20 | 122.97 | 126.44 | 138.95 |
| Days of Payables Outstanding | 70.54 | 171.35 | 160.35 | 152.99 | 144.18 |
| Operating Cycle | 115.90 | 165.71 | 196.86 | 195.50 | 213.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 11.10 | 13.63 | 8.85 | 11.37 | 6.36 |
| Free Cash Flow Per Share | 4.18 | 5.59 | 1.43 | 4.62 | -0.89 |
| Dividend Paid and CapEx Coverage Ratio | 1.59 | 1.68 | 1.16 | 1.66 | 0.84 |
| Capital Expenditure Coverage Ratio | 1.60 | 1.69 | 1.19 | 1.68 | 0.88 |
| Operating Cash Flow Coverage Ratio | 0.27 | 0.25 | 0.16 | 0.21 | 0.11 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.21 | 0.12 | 0.18 | 0.10 |
| Free Cash Flow Yield | 17.70% | 17.86% | 7.45% | 16.14% | -2.51% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 2.99 | 439.61 | -158.66 | 18.84 | 18.96 |
| Price-to-Sales (P/S) Ratio | 0.36 | 0.48 | 0.27 | 0.45 | 0.55 |
| Price-to-Book (P/B) Ratio | 1.33 | 3.24 | 1.79 | 2.59 | 3.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.65 | 5.60 | 13.42 | 6.20 | -39.83 |
| Price-to-Operating Cash Flow Ratio | 2.13 | 2.30 | 2.16 | 2.51 | 5.55 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -2.76 | 1.48 | -1.46 | 11.57 |
| Enterprise Value Multiple | 4.05 | 6.07 | 4.92 | 6.29 | 7.31 |
| Enterprise Value | 424.73M | 619.43M | 527.83M | 617.71M | 656.50M |
| EV to EBITDA | 4.05 | 6.07 | 4.92 | 6.29 | 7.31 |
| EV to Sales | 0.88 | 1.26 | 1.00 | 1.22 | 1.40 |
| EV to Free Cash Flow | 13.80 | 14.84 | 49.59 | 16.86 | -100.80 |
| EV to Operating Cash Flow | 5.19 | 6.08 | 7.99 | 6.84 | 14.04 |
| Tangible Book Value Per Share | -7.36 | -16.16 | -18.33 | -46.79 | -48.59 |
| Shareholders’ Equity Per Share | 17.80 | 9.66 | 10.69 | 11.04 | 11.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.31 | 0.62 | 0.43 | 0.26 | 0.28 |
| Revenue Per Share | 65.50 | 65.77 | 71.01 | 64.00 | 63.73 |
| Net Income Per Share | 7.89 | 0.07 | -0.12 | 1.52 | 1.86 |
| Tax Burden | 3.99 | 0.05 | -0.05 | 0.53 | 0.65 |
| Interest Burden | 0.33 | 0.25 | 0.38 | 0.58 | 0.62 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 9.73 | 65.27 | 8.95 | 5.62 | 3.24 |
Currency in EUR
